MHJC-based large-scale screening of anti-tumor T cells in chronic lymphocytic leukemia reveals CD8+ T cells with specificity against the clonotypic B-cell receptor immunoglobulin

Y. Basavaraju; A. Vardi; A. Agathangelidis; N. W. Pedersen; M. Karypidou; A. Schaap-Johansen; A. Fylaktou; N. Stavroyianni; M. Iskas; A. Anagnostopoulos; A. Chatzidimitriou; P. Marcatili; S. R. Hadrup; K. Stamatopoulos

doi:10.1136/jitc-2022-ITOC9.5

MHJC-based large-scale screening of anti-tumor T cells in chronic lymphocytic leukemia reveals CD8+ T cells with specificity against the clonotypic B-cell receptor immunoglobulin

Y. Basavaraju
, A. Vardi
, A. Agathangelidis
, N. W. Pedersen
, M. Karypidou
, A. Schaap-Johansen
, A. Fylaktou
, N. Stavroyianni
, M. Iskas
, A. Anagnostopoulos
, A. Chatzidimitriou
, P. Marcatili
, S. R. Hadrup
, K. Stamatopoulos

Center for Research and Technology - Hellas
Hippokration General Hospital
Papanikolaou Hospital

Research output: Chapter in Book/Report/Conference proceeding › Conference abstract in proceedings › Research › peer-review

Original language	English
Title of host publication	Proceedings of the 9th Immunotherapy of Cancer Conference
Volume	10
Publisher	BMJ Group
Publication date	2022
Edition	1
Pages	A3-A3
DOIs	https://doi.org/10.1136/jitc-2022-ITOC9.5
Publication status	Published - 2022
Event	9th Immunotherapy of Cancer Conference - Münich, Germany Duration: 22 Sept 2022 → 24 Sept 2022 Conference number: 9

Conference

Conference	9th Immunotherapy of Cancer Conference
Number	9
Country/Territory	Germany
City	Münich
Period	22/09/2022 → 24/09/2022

Access to Document

10.1136/jitc-2022-ITOC9.5

OpenUrl availability

Check availability in DTU Findit

Cite this

Basavaraju, Y., Vardi, A., Agathangelidis, A., Pedersen, N. W., Karypidou, M., Schaap-Johansen, A., Fylaktou, A., Stavroyianni, N., Iskas, M., Anagnostopoulos, A., Chatzidimitriou, A., Marcatili, P., Hadrup, S. R., & Stamatopoulos, K. (2022). MHJC-based large-scale screening of anti-tumor T cells in chronic lymphocytic leukemia reveals CD8+ T cells with specificity against the clonotypic B-cell receptor immunoglobulin. In Proceedings of the 9th Immunotherapy of Cancer Conference (1 ed., Vol. 10, pp. A3-A3). BMJ Group. https://doi.org/10.1136/jitc-2022-ITOC9.5

@inbook{3e5537b1736947dd8aefeab97338a211,

title = " MHJC-based large-scale screening of anti-tumor T cells in chronic lymphocytic leukemia reveals CD8+ T cells with specificity against the clonotypic B-cell receptor immunoglobulin",

author = "Y. Basavaraju and A. Vardi and A. Agathangelidis and Pedersen, \{N. W.\} and M. Karypidou and A. Schaap-Johansen and A. Fylaktou and N. Stavroyianni and M. Iskas and A. Anagnostopoulos and A. Chatzidimitriou and P. Marcatili and Hadrup, \{S. R.\} and K. Stamatopoulos",

year = "2022",

doi = "10.1136/jitc-2022-ITOC9.5",

language = "English",

volume = "10",

pages = "A3--A3",

booktitle = "Proceedings of the 9th Immunotherapy of Cancer Conference",

publisher = "BMJ Group",

edition = "1",

note = "9th Immunotherapy of Cancer Conference, iTOC ; Conference date: 22-09-2022 Through 24-09-2022",

}

Basavaraju, Y, Vardi, A, Agathangelidis, A, Pedersen, NW, Karypidou, M, Schaap-Johansen, A, Fylaktou, A, Stavroyianni, N, Iskas, M, Anagnostopoulos, A, Chatzidimitriou, A, Marcatili, P, Hadrup, SR & Stamatopoulos, K 2022, MHJC-based large-scale screening of anti-tumor T cells in chronic lymphocytic leukemia reveals CD8+ T cells with specificity against the clonotypic B-cell receptor immunoglobulin. in Proceedings of the 9th Immunotherapy of Cancer Conference. 1 edn, vol. 10, BMJ Group, pp. A3-A3, 9th Immunotherapy of Cancer Conference, Münich, Bavaria, Germany, 22/09/2022. https://doi.org/10.1136/jitc-2022-ITOC9.5

MHJC-based large-scale screening of anti-tumor T cells in chronic lymphocytic leukemia reveals CD8+ T cells with specificity against the clonotypic B-cell receptor immunoglobulin. / Basavaraju, Y.; Vardi, A.; Agathangelidis, A. et al.
Proceedings of the 9th Immunotherapy of Cancer Conference. Vol. 10 1. ed. BMJ Group, 2022. p. A3-A3.

Research output: Chapter in Book/Report/Conference proceeding › Conference abstract in proceedings › Research › peer-review

TY - ABST

T1 - MHJC-based large-scale screening of anti-tumor T cells in chronic lymphocytic leukemia reveals CD8+ T cells with specificity against the clonotypic B-cell receptor immunoglobulin

AU - Basavaraju, Y.

AU - Vardi, A.

AU - Agathangelidis, A.

AU - Pedersen, N. W.

AU - Karypidou, M.

AU - Schaap-Johansen, A.

AU - Fylaktou, A.

AU - Stavroyianni, N.

AU - Iskas, M.

AU - Anagnostopoulos, A.

AU - Chatzidimitriou, A.

AU - Marcatili, P.

AU - Hadrup, S. R.

AU - Stamatopoulos, K.

N1 - Conference code: 9

PY - 2022

Y1 - 2022

U2 - 10.1136/jitc-2022-ITOC9.5

DO - 10.1136/jitc-2022-ITOC9.5

M3 - Conference abstract in proceedings

VL - 10

SP - A3-A3

BT - Proceedings of the 9th Immunotherapy of Cancer Conference

PB - BMJ Group

T2 - 9th Immunotherapy of Cancer Conference

Y2 - 22 September 2022 through 24 September 2022

ER -

Basavaraju Y, Vardi A, Agathangelidis A, Pedersen NW, Karypidou M, Schaap-Johansen A et al. MHJC-based large-scale screening of anti-tumor T cells in chronic lymphocytic leukemia reveals CD8+ T cells with specificity against the clonotypic B-cell receptor immunoglobulin. In Proceedings of the 9th Immunotherapy of Cancer Conference. 1 ed. Vol. 10. BMJ Group. 2022. p. A3-A3 doi: 10.1136/jitc-2022-ITOC9.5